GlassScriptPhysician profile
Amy L Kidney
NPI 1710201371
$3,396.39
in general payments reported to CMS, 2019-2025
20 companies · $489 in 2025
The $489 reported for 2025 was more than what 83% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $612 · 2022: $711 · 2023: $998 · 2024: $587 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.24 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $694.42 | 2021-2025 | |
| Aspira Women'S Health INC | $487.51 | 2021-2023 | Ova1 |
| Mayne Pharma Commercial LLC | $289.20 | 2021-2025 | |
| Myriad Women'S Health, INC. | $280.22 | 2023 | Myrisk |
| Astellas Pharma US INC | $252.05 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $218.95 | 2023-2024 | Novasure, Acessa Provu System, Thinprep 2000 Processor |
| Exeltis, USA INC. | $177.86 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $150.31 | 2021-2022 | |
| Coopersurgical, INC. | $149.80 | 2022-2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $143.41 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $140.95 | 2023-2025 | Myfembree |
| Millicent US INC | $127.75 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Organon LLC | $56.01 | 2023 | Nexplanon |
| Agile Therapeutics, INC. | $53.93 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $51.01 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $35.81 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.03 | 2025 | |
| Pfizer INC. | $24.49 | 2023 | |
| Lupin INC. | $22.14 | 2021 | |
| Avion Pharmaceuticals | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kidney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.